C. Vennegoor

700 total citations
19 papers, 590 citations indexed

About

C. Vennegoor is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Immunology. According to data from OpenAlex, C. Vennegoor has authored 19 papers receiving a total of 590 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 10 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in C. Vennegoor's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Immunotherapy and Immune Responses (6 papers) and Cell Adhesion Molecules Research (4 papers). C. Vennegoor is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Immunotherapy and Immune Responses (6 papers) and Cell Adhesion Molecules Research (4 papers). C. Vennegoor collaborates with scholars based in Netherlands. C. Vennegoor's co-authors include H. Bloemendal, Jero Calafat, D. J. Ruiter, P Hageman, P Rümke, A.L.H. Stols, Ph. Hageman, Hans Janßen, A H Kolk and J E de Vries and has published in prestigious journals such as The Journal of Immunology, Journal of Molecular Biology and Methods in enzymology on CD-ROM/Methods in enzymology.

In The Last Decade

C. Vennegoor

19 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Vennegoor Netherlands 10 314 179 145 122 105 19 590
Leonid Meromsky United States 13 500 1.6× 221 1.2× 104 0.7× 122 1.0× 64 0.6× 15 720
Rose Marie Nagy United States 10 378 1.2× 76 0.4× 77 0.5× 197 1.6× 223 2.1× 26 607
G. A. Luckenbach Germany 11 200 0.6× 157 0.9× 119 0.8× 68 0.6× 148 1.4× 16 434
Laura Giuffrè Switzerland 11 279 0.9× 348 1.9× 257 1.8× 154 1.3× 280 2.7× 15 775
Sergei F. Barbashov United States 7 380 1.2× 289 1.6× 75 0.5× 86 0.7× 119 1.1× 12 689
Florian Peters Germany 12 142 0.5× 241 1.3× 77 0.5× 96 0.8× 72 0.7× 20 478
Eric Lynam United States 9 231 0.7× 195 1.1× 55 0.4× 79 0.6× 254 2.4× 11 520
Joseph Z. Zaretsky Israel 11 574 1.8× 227 1.3× 241 1.7× 107 0.9× 36 0.3× 13 706
Ph. Hageman Netherlands 7 385 1.2× 196 1.1× 279 1.9× 183 1.5× 47 0.4× 10 636
Marina Kiso Japan 4 410 1.3× 176 1.0× 123 0.8× 120 1.0× 182 1.7× 5 577

Countries citing papers authored by C. Vennegoor

Since Specialization
Citations

This map shows the geographic impact of C. Vennegoor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Vennegoor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Vennegoor more than expected).

Fields of papers citing papers by C. Vennegoor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Vennegoor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Vennegoor. The network helps show where C. Vennegoor may publish in the future.

Co-authorship network of co-authors of C. Vennegoor

This figure shows the co-authorship network connecting the top 25 collaborators of C. Vennegoor. A scholar is included among the top collaborators of C. Vennegoor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Vennegoor. C. Vennegoor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Vennegoor, C., E. van de Wiel-van Kemenade, Richard Huijbens, et al.. (1992). Role of LFA-1 and VLA-4 in the adhesion of cloned normal and LFA-1 (CD11/CD18)-deficient T cells to cultured endothelial cells. Indication for a new adhesion pathway. The Journal of Immunology. 148(4). 1093–1101. 34 indexed citations
2.
Ringens, Peter J., Rien van Haperen, C. Vennegoor, et al.. (1989). Monoclonal antibodies in detection of choroidal melanoma. Graefe s Archive for Clinical and Experimental Ophthalmology. 227(3). 287–290. 7 indexed citations
3.
Gruters, Rob A., Jero Calafat, C. Vennegoor, Hans Jansen, & Hidde L. Ploegh. (1989). Structural heterogeneity of a human melanoma-associated antigen.. PubMed. 49(2). 459–65. 3 indexed citations
4.
Vennegoor, C., et al.. (1988). A monoclonal antibody specific for cells of the melanocyte lineage.. PubMed. 130(1). 179–92. 126 indexed citations
5.
Mullink, H., et al.. (1987). Classification of routinely processed anaplastic large cell tumours with a small panel of antibodies. An immunohistochemical study with clinical follow-up.. PubMed. 2(2). 107–18. 6 indexed citations
6.
Jager, Martine J., et al.. (1987). Heterogeneous expression of melanoma-associated antigens in uveal melanomas. Current Eye Research. 6(6). 757–765. 28 indexed citations
7.
Vennegoor, C., et al.. (1986). Circulating melanoma-associated antigen detected by monoclonal antibody NKI/C-3. Cancer Immunology Immunotherapy. 23(2). 93–100. 20 indexed citations
8.
Hagen, E. Christiaan, C. Vennegoor, Reinier O. Schlingemann, E. A. van der Velde, & D. J. Ruiter. (1986). Correlation of histopathological characteristics with staining patterns in human melanoma assessed by (monoclonal) antibodies reactive on paraffin sections. Histopathology. 10(7). 689–700. 31 indexed citations
9.
Vennegoor, C., Jero Calafat, Ph. Hageman, et al.. (1985). Biochemical characterization and cellular localization of a formalin‐resistant melanoma‐associated antigen reacting with monoclonal antibody NKI/C‐3. International Journal of Cancer. 35(3). 287–295. 94 indexed citations
10.
Vennegoor, C., et al.. (1982). Monoclonal antibodies against Mycoplasma hyorhinis. Experimental Cell Research. 137(1). 89–94. 7 indexed citations
11.
Dullens, Hub F. J., et al.. (1979). Comparison of various forms of therapy in two different mouse tumor systems.. PubMed. 63(1). 99–109. 6 indexed citations
12.
Dullens, Hub F. J., R.A. De Weger, C. Vennegoor, & Willem Den Otter. (1979). Anti-tumour effect of chlorambucil-antibody complexes in a murine melanoma system. European Journal of Cancer (1965). 15(1). 69–75. 8 indexed citations
13.
Vennegoor, C., et al.. (1975). Effects of mixtures and complexes of chlorambucil and antibody on a human melanoma cell line. European Journal of Cancer (1965). 11(10). 725–732. 7 indexed citations
14.
Cornain, Santoso, et al.. (1975). Antibodies and antigen expression in human melanoma detected by the immune adherence test. International Journal of Cancer. 16(6). 981–997. 40 indexed citations
15.
Vennegoor, C. & H. Bloemendal. (1974). [47] Particle character of aminoacyl-tRNA synthetases isolated from a postmicrosomal fraction. Methods in enzymology on CD-ROM/Methods in enzymology. 29. 584–600. 6 indexed citations
16.
Vennegoor, C., A.L.H. Stols, & H. Bloemendal. (1972). More evidence for a particle character of aminoacyl-transfer RNA synthetases isolated from rat liver. Journal of Molecular Biology. 65(2). 375–378. 46 indexed citations
17.
Vennegoor, C. & H. Bloemendal. (1972). Occurrence and Particle Character of Aminoacyl‐tRNA Synthetases in the Post‐Microsomal Fraction from Rat Liver. European Journal of Biochemistry. 26(4). 462–473. 98 indexed citations
18.
Vennegoor, C. & H. Bloemendal. (1970). Effect of a Purified Post-Microsomal Fraction on Amino Acid Incorporation in vitro. European Journal of Biochemistry. 15(1). 161–170. 20 indexed citations
19.
Bloemendal, H., C. Vennegoor, & R.N.H. Konings. (1969). Synthesis of lens protein in vitro IV. Further characterization of the lens cell-free system. Experimental Eye Research. 8(2). 220–226. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leonid Meromsky Breakdown of academic impact, for papers by Rose Marie Nagy Breakdown of academic impact, for papers by G. A. Luckenbach Breakdown of academic impact, for papers by Laura Giuffrè Breakdown of academic impact, for papers by Sergei F. Barbashov Breakdown of academic impact, for papers by Florian Peters Breakdown of academic impact, for papers by Eric Lynam Breakdown of academic impact, for papers by Joseph Z. Zaretsky Breakdown of academic impact, for papers by Ph. Hageman Breakdown of academic impact, for papers by Marina Kiso
Rankless by CCL
2026